CoreCap Advisors’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-290	Closed	-$403	–	3228
2025 Q1	$403	Sell	290 -90	-24%	-$125	﹤0.01%	2753
2024 Q4	$657	Buy	+380	New	+$657	﹤0.01%	2444